These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38958683)

  • 1. The effect of Empagliflozin on echocardiographic parameters in diabetic patients after acute myocardial infarction: A systematic review and meta-analysis with trial sequential analysis.
    Mouffokes A; Soliman Y; Amer BE; Umar TP; Gonnah AR; Ellabban MH; Abdelazeem B
    Ir J Med Sci; 2024 Jul; ():. PubMed ID: 38958683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
    Udell JA; Petrie MC; Jones WS; Anker SD; Harrington J; Mattheus M; Seide S; Amir O; Bahit MC; Bauersachs J; Bayes-Genis A; Chen Y; Chopra VK; Figtree G; Ge J; Goodman SG; Gotcheva N; Goto S; Gasior T; Jamal W; Januzzi JL; Jeong MH; Lopatin Y; Lopes RD; Merkely B; Martinez-Traba M; Parikh PB; Parkhomenko A; Ponikowski P; Rossello X; Schou M; Simic D; Steg PG; Szachniewicz J; van der Meer P; Vinereanu D; Zieroth S; Brueckmann M; Sumin M; Bhatt DL; Hernandez AF; Butler J
    J Am Coll Cardiol; 2024 Jun; 83(23):2233-2246. PubMed ID: 38588929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials involving 2624 patients.
    Tanashat M; Manasrah A; Abouzid M
    Eur J Clin Pharmacol; 2024 Jul; 80(7):951-963. PubMed ID: 38498097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.
    Aziz F; Tripolt NJ; Pferschy PN; Scharnagl H; Abdellatif M; Oulhaj A; Benedikt M; Kolesnik E; von Lewinski D; Sourij H
    Cardiovasc Diabetol; 2024 Apr; 23(1):145. PubMed ID: 38678253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empagliflozin in acute myocardial infarction: the EMMY trial.
    von Lewinski D; Kolesnik E; Tripolt NJ; Pferschy PN; Benedikt M; Wallner M; Alber H; Berger R; Lichtenauer M; Saely CH; Moertl D; Auersperg P; Reiter C; Rieder T; Siller-Matula JM; Gager GM; Hasun M; Weidinger F; Pieber TR; Zechner PM; Herrmann M; Zirlik A; Holman RR; Oulhaj A; Sourij H
    Eur Heart J; 2022 Nov; 43(41):4421-4432. PubMed ID: 36036746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sodium-glucose cotransporter-2 inhibitors on cardiac structure remodeling and function: A meta-analysis of randomized controlled trials.
    Fan G; Guo DL
    Eur J Intern Med; 2023 Aug; 114():49-57. PubMed ID: 37062643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.
    Tripolt NJ; Kolesnik E; Pferschy PN; Verheyen N; Ablasser K; Sailer S; Alber H; Berger R; Kaulfersch C; Leitner K; Lichtenauer M; Mader A; Moertl D; Oulhaj A; Reiter C; Rieder T; Saely CH; Siller-Matula J; Weidinger F; Zechner PM; von Lewinski D; Sourij H;
    Am Heart J; 2020 Mar; 221():39-47. PubMed ID: 31901799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMMY: The continued expansion of clinical applications of SGLT2 inhibitors.
    Kotit S
    Glob Cardiol Sci Pract; 2023 Jan; 2023(1):e202305. PubMed ID: 36890845
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
    Lee MMY; Brooksbank KJM; Wetherall K; Mangion K; Roditi G; Campbell RT; Berry C; Chong V; Coyle L; Docherty KF; Dreisbach JG; Labinjoh C; Lang NN; Lennie V; McConnachie A; Murphy CL; Petrie CJ; Petrie JR; Speirits IA; Sourbron S; Welsh P; Woodward R; Radjenovic A; Mark PB; McMurray JJV; Jhund PS; Petrie MC; Sattar N
    Circulation; 2021 Feb; 143(6):516-525. PubMed ID: 33186500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium-glucose cotransporter 2 inhibitors on cardiac structure and function in type 2 diabetes mellitus patients with or without chronic heart failure: a meta-analysis.
    Yu YW; Zhao XM; Wang YH; Zhou Q; Huang Y; Zhai M; Zhang J
    Cardiovasc Diabetol; 2021 Jan; 20(1):25. PubMed ID: 33494751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial.
    Khiali S; Taban-Sadeghi M; Sarbakhsh P; Khezerlouy-Aghdam N; Namdar H; Salehi R; Rezagholizadeh A; Entezari-Maleki T
    Trials; 2023 Oct; 24(1):645. PubMed ID: 37803449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers in patients without heart failure after myocardial infarction.
    Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison the effects of finerenone and SGLT2i on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus: A network meta-analysis.
    Li X; Wu H; Peng H; Jiang H
    Front Endocrinol (Lausanne); 2022; 13():1078686. PubMed ID: 36589800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial infarction.
    Zhou X; Zhu H; Zheng Y; Tan X; Tong X
    Front Cardiovasc Med; 2022; 9():953948. PubMed ID: 36304540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Empagliflozin Post Myocardial Infarction.
    Ravendran K; Madouros N; Yoztyurk E; Wilson A; Jeejo MJ; Camelio ME; Sinha A; George A; Rai M; Malik HK
    Cureus; 2023 Jun; 15(6):e40602. PubMed ID: 37469808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empagliflozin in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pan D; Xu L; Chen P; Jiang H; Shi D; Guo M
    Front Cardiovasc Med; 2021; 8():683281. PubMed ID: 34239906
    [No Abstract]   [Full Text] [Related]  

  • 18. Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial.
    Khiali S; Taban-Sadeghi M; Sarbakhsh P; Khezerlouy-Aghdam N; Entezari-Maleki T
    Eur J Clin Pharmacol; 2024 Jan; 80(1):93-104. PubMed ID: 37897527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis.
    Zhang N; Wang Y; Tse G; Korantzopoulos P; Letsas KP; Zhang Q; Li G; Lip GYH; Liu T
    Eur J Prev Cardiol; 2022 Feb; 28(17):1961-1973. PubMed ID: 34792124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
    Shimizu W; Kubota Y; Hoshika Y; Mozawa K; Tara S; Tokita Y; Yodogawa K; Iwasaki YK; Yamamoto T; Takano H; Tsukada Y; Asai K; Miyamoto M; Miyauchi Y; Kodani E; Ishikawa M; Maruyama M; Ogano M; Tanabe J;
    Cardiovasc Diabetol; 2020 Sep; 19(1):148. PubMed ID: 32977831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.